BOULDER, Colo.–(BUSINESS WIRE)– Edgewise Therapeutics, Inc., (NASDAQ:EWTX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering of $100 million of its common stock. In addition, Edgewise Therapeutics intends to grant the underwriters a 30-day option to purchase up to an additional $15.0 million of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock in this offering will be sold by Edgewise. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Tencent’s Chief Exploration Officer Steps Down Amid China’s Gaming, Tech Crackdown
Tencent Holdings Ltd.'s (OTC: TCEHY) Chief Exploration Officer, David Wallerstein, is stepping down from his management role amidst China's crackdown on
